为严格落实绩效考核对科研工作的具体要求，精神医学研究中心在医院领导的关心和大力支持以及全体科研人员的共同努力下取得了可喜的成绩。今年参与了国家自然基金申请9项，获批准面上项目1项（由张向阳博士获得），参与申请北京市自然基金4项。截止到8月已发表SCI论文7篇，分别是：
       赵艳丽发表于Psychological Medicine 的“Neural correlates of the abolished self-referential memory effect in schizophrenia”（IF：5.587）；
       朱小林发表于Neuroscience Letters的“Visual scanning of emotional faces in schizophrenia”（IF：2.026）；
       范丰梅发表于Neuroscience Bulletin 的“Ventral medial prefrontal functional connectivity and emotion regulation in chronic schizophrenia: A pilot study”（IF：1.36）；
       张向阳、修梅红发表于Brain Behav Immun的“Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls”（IF：5.612）；
       石晶发表于Acta Pharmacologica Sinica 的“Pharmacokinetics and dopamine /acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats” （IF：1.95）；
       王帆发表于Plos one 的“Interaction between IL10 and DBH polymorphisms is associated with tardive dyskinesia in Chinese Han schizophrenic patients” （IF：4.092）；
       安会梅发表于Behavioral Pharmacology的“Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia” （IF：2.96）。